AI Engines For more Details: Perplexity Kagi Labs You
Nutrient Density: Whole cow's milk is an excellent source of essential nutrients, including calcium, vitamin D, vitamin B12, phosphorus, potassium, and riboflavin. These nutrients play crucial roles in bone health, immune function, energy metabolism, and overall well-being.
Bone Health: The calcium and vitamin D content of whole cow's milk are essential for maintaining strong and healthy bones. Adequate calcium intake during childhood and adolescence is particularly important for bone development and can help reduce the risk of osteoporosis and fractures later in life.
Muscle Growth and Repair: The high-quality protein found in whole cow's milk, including casein and whey protein, supports muscle growth, repair, and maintenance. Consuming milk after exercise can help replenish glycogen stores, promote muscle recovery, and enhance muscle protein synthesis.
Heart Health: Despite containing saturated fat, moderate consumption of whole cow's milk has not been consistently linked to an increased risk of cardiovascular disease in healthy individuals. Some studies suggest that dairy fat may have neutral or beneficial effects on cardiovascular health, potentially due to its unique fatty acid profile and associated nutrients.
Weight Management: Contrary to common misconceptions, moderate consumption of whole cow's milk may not necessarily lead to weight gain or obesity. Some research suggests that dairy products, including milk, may actually be associated with lower body weight, reduced body fat, and improved metabolic health when consumed as part of a balanced diet.
Childhood Growth and Development: Whole cow's milk is a staple food for infants and young children due to its nutrient density and role in supporting growth and development. It provides essential nutrients like protein, calcium, and vitamin D necessary for building strong bones, muscles, and teeth.
Improved Hydration: Milk is a hydrating beverage that can help replenish fluids and electrolytes lost through sweating and physical activity. It contains a balance of water, carbohydrates, protein, and electrolytes, making it an effective rehydration option for individuals of all ages.
Neurological Health: Some research suggests that certain components of whole cow's milk, such as vitamin B12 and choline, may support neurological health and cognitive function. Adequate intake of these nutrients during infancy, childhood, and adulthood may help maintain brain health and reduce the risk of cognitive decline with aging.
| Rank | Probiotic | Impact |
|---|---|---|
| order | Micrococcales | Increases |
| species | Bifidobacterium adolescentis | Increases |
| species | Bifidobacterium bifidum | Increases |
| species | Bifidobacterium breve | Increases |
| species | Bifidobacterium catenulatum | Increases |
| species | Bifidobacterium longum | Increases |
| species | Bifidobacterium pseudocatenulatum | Increases |
| species | Escherichia coli | Reduces |
| species | Lactobacillus acidophilus | Increases |
| species | Lactobacillus crispatus | Increases |
| species | Lactobacillus gasseri | Increases |
| species | Lactobacillus helveticus | Increases |
| species | Lactobacillus jensenii | Increases |
| species | Lactobacillus johnsonii | Increases |
| species | Lactobacillus kefiranofaciens | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 2.1 | 2.1 | |
| ADHD | 1.7 | 2.7 | -0.59 |
| Age-Related Macular Degeneration and Glaucoma | 0.3 | 0.3 | |
| Allergic Rhinitis (Hay Fever) | 3.5 | 0.2 | 16.5 |
| Allergies | 2.1 | 2.6 | -0.24 |
| Allergy to milk products | 1.1 | 1.3 | -0.18 |
| Alopecia (Hair Loss) | 0.9 | -0.9 | |
| Alzheimer's disease | 4.7 | 2.7 | 0.74 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.6 | 2.4 | -0.5 |
| Ankylosing spondylitis | 3.1 | 3 | 0.03 |
| Anorexia Nervosa | 1.1 | 0.6 | 0.83 |
| Antiphospholipid syndrome (APS) | 0.2 | 0.2 | |
| Asthma | 0.9 | 1.1 | -0.22 |
| Atherosclerosis | 0.5 | 1.8 | -2.6 |
| Atrial fibrillation | 0.6 | 3.4 | -4.67 |
| Autism | 5.1 | 5.8 | -0.14 |
| benign prostatic hyperplasia | 1 | 1 | |
| Bipolar Disorder | 1 | 1.7 | -0.7 |
| Brain Trauma | 0.8 | 0.9 | -0.13 |
| Carcinoma | 1.7 | 1.2 | 0.42 |
| Celiac Disease | 2.2 | 2 | 0.1 |
| Cerebral Palsy | 0.6 | 0.6 | 0 |
| Chronic Fatigue Syndrome | 1.7 | 0.8 | 1.13 |
| Chronic Kidney Disease | 2.4 | 0.5 | 3.8 |
| Chronic Lyme | 0.3 | 0.3 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | -0.9 | |
| Chronic Urticaria (Hives) | 0.7 | 1.2 | -0.71 |
| Coagulation / Micro clot triggering bacteria | 1.8 | 0.6 | 2 |
| Colorectal Cancer | 2.5 | 1.1 | 1.27 |
| Constipation | 2 | 1.2 | 0.67 |
| Coronary artery disease | 1.4 | 0.5 | 1.8 |
| COVID-19 | 5.4 | 4.7 | 0.15 |
| Crohn's Disease | 5.5 | 3.8 | 0.45 |
| cystic fibrosis | 1.3 | 0.6 | 1.17 |
| deep vein thrombosis | 1.2 | 1.2 | |
| Depression | 5.5 | 6 | -0.09 |
| Dermatomyositis | 0.6 | 0.6 | |
| Eczema | 2.4 | 0.2 | 11 |
| Endometriosis | 2.3 | 1.8 | 0.28 |
| Epilepsy | 4.2 | 2.6 | 0.62 |
| erectile dysfunction | 0.3 | -0.3 | |
| Fibromyalgia | 1.7 | 1 | 0.7 |
| Functional constipation / chronic idiopathic constipation | 3.6 | 2 | 0.8 |
| gallstone disease (gsd) | 1.1 | 0.9 | 0.22 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 0.6 | |
| Generalized anxiety disorder | 2 | 0.8 | 1.5 |
| Glioblastoma | 0.3 | 0.3 | |
| Gout | 0.5 | 0.5 | |
| Graves' disease | 1.1 | 2.9 | -1.64 |
| Hashimoto's thyroiditis | 0.9 | 1.7 | -0.89 |
| Histamine Issues,Mast Cell Issue, DAO Insufficiency | 2.1 | 1 | 1.1 |
| hypercholesterolemia (High Cholesterol) | 0.5 | 0.5 | |
| hyperglycemia | 3 | 0.5 | 5 |
| Hyperlipidemia (High Blood Fats) | 0.9 | 1.2 | -0.33 |
| hypersomnia | 0.8 | 0.8 | |
| hypertension (High Blood Pressure | 3.1 | 2.4 | 0.29 |
| Hypothyroidism | 2.1 | 0.6 | 2.5 |
| Hypoxia | 0.6 | -0.6 | |
| IgA nephropathy (IgAN) | 1.7 | 0.3 | 4.67 |
| Inflammatory Bowel Disease | 3.7 | 2 | 0.85 |
| Insomnia | 2.6 | -2.6 | |
| Intelligence | 0.3 | -0.3 | |
| Intracranial aneurysms | 0.6 | 0.6 | 0 |
| Irritable Bowel Syndrome | 4.5 | 2.1 | 1.14 |
| Juvenile idiopathic arthritis | 0.6 | -0.6 | |
| Liver Cirrhosis | 2.5 | 2.1 | 0.19 |
| Long COVID | 5.6 | 5.6 | 0 |
| Low bone mineral density | 0.3 | 0.3 | |
| Lung Cancer | 1.9 | 1.9 | |
| ME/CFS with IBS | 0.8 | 0.8 | |
| ME/CFS without IBS | 0.6 | 0.2 | 2 |
| Menopause | 0.4 | 0.4 | 0 |
| Metabolic Syndrome | 5 | 5 | 0 |
| Mood Disorders | 6 | 7.3 | -0.22 |
| multiple chemical sensitivity [MCS] | 0.6 | 0.6 | 0 |
| Multiple Sclerosis | 1.1 | 4.4 | -3 |
| Multiple system atrophy (MSA) | 1.4 | 1.3 | 0.08 |
| myasthenia gravis | 0.3 | -0.3 | |
| Neuropathy (all types) | 2 | -2 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4 | 2.5 | 0.6 |
| NonCeliac Gluten Sensitivity | 0.6 | 0.6 | |
| Obesity | 3.5 | 3.7 | -0.06 |
| obsessive-compulsive disorder | 3.7 | 0.2 | 17.5 |
| Osteoarthritis | 0.7 | 0.5 | 0.4 |
| Osteoporosis | 2.2 | 1.1 | 1 |
| Parkinson's Disease | 3.9 | 2.5 | 0.56 |
| Polycystic ovary syndrome | 1.9 | 1.5 | 0.27 |
| Postural orthostatic tachycardia syndrome | 0.8 | 0.8 | |
| Premenstrual dysphoric disorder | 1.2 | -1.2 | |
| primary biliary cholangitis | 0.5 | -0.5 | |
| Psoriasis | 0.9 | 3 | -2.33 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.3 | 4.6 | -0.07 |
| Rosacea | 0.6 | 2 | -2.33 |
| Schizophrenia | 2.9 | 3.8 | -0.31 |
| scoliosis | 0.3 | -0.3 | |
| sensorineural hearing loss | 0.3 | 0.3 | |
| Sjögren syndrome | 3.9 | 0.8 | 3.88 |
| Sleep Apnea | 3.1 | 1.2 | 1.58 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | 0.6 | |
| Stress / posttraumatic stress disorder | 3 | 1.2 | 1.5 |
| Systemic Lupus Erythematosus | 4.8 | 1.4 | 2.43 |
| Tic Disorder | 0.6 | 0.6 | |
| Tourette syndrome | 0.6 | 0.6 | |
| Type 1 Diabetes | 1.5 | 2 | -0.33 |
| Type 2 Diabetes | 4.1 | 4.6 | -0.12 |
| Ulcerative colitis | 2.9 | 4.9 | -0.69 |
| Unhealthy Ageing | 1 | 1.1 | -0.1 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.